Table 2.

Demographics and clinical presentation of Primary splenic lymphomas:

	Age/sex	Presenting complaints	Primary diagnosis	Management	Patient status
1	62/M	Splenomegaly and B-symptoms	SMZL	Splenectomy	Alive
2	37/M	Splenomegaly with hilar lymphadenopathy and B-symptoms	SMZL	CVP followed by Splenectomy	Alive
3	14/M	B symptoms with splenomegaly	PTCL, NOS	Splenectomy + Chemo	Died
4	64/M	Splenomegaly	SMZL	Splenectomy	Alive
5	54/F	Splenomegaly with B-symptoms	SDRPL	Splenectomy Had leukemic phase	Died
6	58/M	Splenomegaly	SMZL	Splenectomy	Alive
7	52/M	Splenomegaly	SMZL
8	48/M	Splenomegaly	SMZL
9	50/M	Splenomegaly	SMZL	Splenectomy	Alive
10	52/F	Splenomegaly	SMZL	Splenectomy	Alive
11	59/F	Splenomegaly	SMZL	Splenectomy
12	54/F	Splenomegaly	SMZL	Splenectomy	Alive
13	65/F	Splenomegaly	SMZL
14	54/F	Splenomegaly	SMZL	Splenectomy	Alive
15	51/M	Splenomegaly	Follicular T–cell Lymphoma	Splenectomy + Chemo	Alive
16	19/F	Splenomegaly with menorrhagia	HSTCL	VCR	Alive
17	25/M	Splenomegaly	DLBCL		Lost to follow up
18	59/F	Splenomegaly	DLBCL	Splenectomy	Alive
19	56/M	Splenomegaly	DLBCL	Splenectomy	Alive
20	27/M	Splenomegaly	DLBCL		Alive
21	22/F	Splenomegaly	HSTCL		Alive
22	41/M	Splenomegaly with hepatomegaly	HSTCL	Splenectomy	Alive
23	66/M	Splenomegaly	Gray zone lymphoma	Splenectomy	Alive
24	7/F	Splenomegaly	Splenic B-cell lymphoma, unclassifiable	Splenectomy	Alive
25	46/M	Splenomegaly	SMZL	Splenectomy	Alive
26	50/F	Splenomegaly	SMZL		Alive
27	50/F	Splenomegaly	SMZL	Splenectomy	Alive
28	63/F	Splenomegaly	Hairy cell leukemia, variant	Splenectomy	Alive

**Few patients were lost to follow up

PTCL Peripheral T cell Lymphoma, SMZL Splenic Marginal Zone lymphoma, SDPRL Splenic Diffuse red pulp Lymphoma, DLBCL Diffuse large B-cell lymphoma